Navigating the Dynamic Landscape of SARS-CoV-2: The Dual Role of Neutralizing Antibodies, Variability in Responses, and Strategies for Adaptive Pandemic Control

Author:

Iyer Venkatesh Anand1,Mohan Aditi1,Kumar Dharmender2ORCID,Dahiya Praveen1ORCID

Affiliation:

1. Amity Institute of Biotechnology, Amity University Uttar Pradesh, Sector-125, Noida 201313, Uttar Pradesh, India

2. Department of Biotechnology, Deenbandhu Chhotu Ram University of Science &Technology, Murthal, Sonipat 131309, Haryana, India

Abstract

The global pandemic sparked by the emergence of SARS-CoV-2 and its variants has imposed a substantial burden of morbidity and mortality. Central to the battle against these viral threats is the immune response, with a spotlight on the pivotal role played by neutralizing antibodies. This comprehensive review delves into current research, unravelling the dual functionality of neutralizing antibodies acting as formidable barriers to viral replication and crucial facilitators of adaptive immune memory. Beyond this dual purpose, the review illuminates the nuanced variability characterizing neutralizing antibody responses to SARS-CoV-2. Emphasizing the dynamic nature of these responses, the review advocates for the plausible challenges in targeted therapeutic interventions. This review also attempts to compare various vaccination approaches and their impact on SARS-CoV-2, as well as offer insights into various Omicron variations. Recognizing the ever-evolving viral landscape, this exploration underscores the necessity of flexible approaches to address the diverse challenges posed by SARS-CoV-2 and its variants, contributing valuable insights to the ongoing global efforts in pandemic mitigation and public health safeguarding.

Publisher

MDPI AG

Reference123 articles.

1. A perspective on early detection systems models for COVID-19 spreading;Vianello;Biochem. Biophys. Res. Commun.,2021

2. COVID-19 Pandemic: Assessment of current strategies and socio-economic Impact;Bhargava;J. Health Manag.,2022

3. Pattern recognition receptors in health and diseases;Li;Signal Transduct. Target. Ther.,2021

4. Natural killer cells in cancer and cancer immunotherapy;Raskov;Cancer Lett.,2021

5. Cross-neutralizing activity against SARS-CoV-2 variants in COVID-19 patients: Comparison of 4 waves of the pandemic in Japan;Furukawa;InOpen Forum Infect. Dis.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3